We are a team of experts with over 30 years of experience in hematopoietic stem cell transplantation and cellular therapy.
We partner with health care centers to navigate the complex process of building the infrastructure, clinical operations, and regulatory frameworks needed to safely deliver advanced cell therapies.
Our mission is to make healthcare innovation accessible—ensuring that cellular therapy becomes a reality for all who need it, both in the United States and globally. We believe no one should suffer from a treatable condition.
Transforming a community healthcare center into a facility capable of delivering safe and effective cellular therapy is incredibly challenging—and it requires deep, specialized expertise. That’s why we created CellServe.
What we offer is a level of hands-on guidance that only comes from decades of experience. Our team has grown with the field, from the early days of hematopoietic transplantation to the latest advances in CAR T-cells. therapy. We are excited to share what we’ve learned with you and help you bring this treatment closer to home.
Bringing our healthcare innovations directly to communities to break down geographic, social, and economic barriers and ensure immediate access for all.
CellServe is comprised of premier researchers and hematologists/oncologists. We are a team with unique, complementary, and synergistic skills honed during years of experience in the field.
Ms. Williamson has over 20 years of leadership and business management experience with expertise in healthcare finance, scaling complex projects and organizations, and providing optimal cancer patient care.
Dr. De Lima has been instrumental in developing and facilitating the manufacturing of CAR T-cells at points of care in the U.S. and globally. He has been a dedicated clinician, clinical investigator, and leader in the field of Hematopoietic Stem Cell Transplantation (HSCT) for over 30 years.
Dr. Wald pioneers cutting-edge manufacturing technologies in his laboratory, including CAR T-cells and other products that are not only intended to improve outcomes and tolerance of cellular therapy, but to broaden access to these products.
Copyright 2025 © Cellserve LLC All Right Reserved – Made with by the nerds of MetaTech